Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC607 for Acute Kidney Injury in Cardiac Surgery
NCT01602328Phase 2Terminated
- Sponsor
- AlloCure
- Start
- Jun 2012
- Primary completion
- Jun 2014
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of AC607 in acute kidney injury (AKI), sponsored by AlloCure. Started Jun 2012; status: terminated.
02
Drugs
AC607
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01602328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602328.